Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Status:
Not yet recruiting

Trial end date:
2023-05-23

Target enrollment:

Participant gender:

This study will evaluate efficacy and safety of GSK1070806 in moderate to severe atopic dermatitis (AtD) participants.

Phase 1

GlaxoSmithKline